PAR paradigm biopharmaceuticals limited..

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-48

  1. 2,000 Posts.
    lightbulb Created with Sketch. 2324
    Ox, 50% dosed +112 days to reach the data required for IA, no? If required, the remaining 50% should only add a few more months to the timeline, since everything trial-related should be up and running steady-state by that stage. You're right though, that'll likely not be early 2026.

    https://hotcopper.com.au/data/attachments/6838/6838810-ae55a6f2f2654f44e40f7ae5185ecbcf.jpg

    ^According to this AGM slide, that 50% is targeted for recruitment in 2H CY2025. Dosing takes 39 days, then add 112 for IA. In total, roughly 5 months after we get notification of 50% recruitment, we'll have the data for IA. Not sure how long after the data is collected before readout. Probably give it another month at least, so 6 months after 50% recruitment.

    2H is a big period, so if (in a world first) PAR over-deliver and achieve this in July, the +6 months is January 2026. I reckon thats wildly optimistic, and we should measure from 31st December 2025, giving us a readout around July 2026. We can set our watches with a lot more certainty when we get notification of 50% recruitment though.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.5¢
Change
0.035(12.1%)
Mkt cap ! $126.5M
Open High Low Value Volume
29.0¢ 33.5¢ 29.0¢ $692.3K 2.176M

Buyers (Bids)

No. Vol. Price($)
1 11161 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 134295 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.